223 related articles for article (PubMed ID: 15606694)
1. The TGF-beta 1 gene codon 10 polymorphism contributes to the genetic predisposition to nephropathy in Type 1 diabetes.
Patel A; Scott WR; Lympany PA; Rippin JD; Gill GV; Barnett AH; Bain SC;
Diabet Med; 2005 Jan; 22(1):69-73. PubMed ID: 15606694
[TBL] [Abstract][Full Text] [Related]
2. [Role of transforming growth factor beta-1 gene polymorphisms in the development of chronic allograft nephropathy in renal transplant recipients].
Iñigo P; Lario S; Campistol JM; Bescós M; Campos B; Oppenheimer F
Nefrologia; 2003; 23(4):312-20. PubMed ID: 14558330
[TBL] [Abstract][Full Text] [Related]
3. Resequencing of genes for transforming growth factor beta1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy.
McKnight AJ; Savage DA; Patterson CC; Sadlier D; Maxwell AP
BMC Med Genet; 2007 Feb; 8():5. PubMed ID: 17319955
[TBL] [Abstract][Full Text] [Related]
4. Significant correlation between association of polymorphism in codon 10 of transforming growth factor-beta1 T (29) C with type 1 diabetes and patients with nephropathy disorder.
Jahromi MM; Millward BA; Demaine AG
J Interferon Cytokine Res; 2010 Feb; 30(2):59-66. PubMed ID: 20039825
[TBL] [Abstract][Full Text] [Related]
5. Gene polymorphism of transforming growth factor-β1 in Egyptian patients with type 2 diabetes and diabetic nephropathy.
El-Sherbini SM; Shahen SM; Mosaad YM; Abdelgawad MS; Talaat RM
Acta Biochim Biophys Sin (Shanghai); 2013 Apr; 45(4):330-8. PubMed ID: 23399816
[TBL] [Abstract][Full Text] [Related]
6. Association of aldose reductase gene Z+2 polymorphism with reduced susceptibility to diabetic nephropathy in Caucasian Type 1 diabetic patients.
Lajer M; Tarnow L; Fleckner J; Hansen BV; Edwards DG; Parving HH; Boel E
Diabet Med; 2004 Aug; 21(8):867-73. PubMed ID: 15270790
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta in human diabetic nephropathy: effects of ACE inhibition.
Langham RG; Kelly DJ; Gow RM; Zhang Y; Cordonnier DJ; Pinel N; Zaoui P; Gilbert RE
Diabetes Care; 2006 Dec; 29(12):2670-5. PubMed ID: 17130203
[TBL] [Abstract][Full Text] [Related]
8. Role of alpha-adducin DNA polymorphisms in the genetic predisposition to diabetic nephropathy.
Conway BR; Martin R; McKnight AJ; Savage DA; Brady HR; Maxwell AP
Nephrol Dial Transplant; 2004 Aug; 19(8):2019-24. PubMed ID: 15187197
[TBL] [Abstract][Full Text] [Related]
9. Association between transforming growth factor beta1 gene polymorphisms and IgA nephropathy.
Carturan S; Roccatello D; Menegatti E; Di Simone D; Davit A; Piazza A; Sena LM; Matullo G
J Nephrol; 2004; 17(6):786-93. PubMed ID: 15593052
[TBL] [Abstract][Full Text] [Related]
10. Association of VEGF-1499C-->T polymorphism with diabetic nephropathy in type 1 diabetes mellitus.
McKnight AJ; Maxwell AP; Patterson CC; Brady HR; Savage DA
J Diabetes Complications; 2007; 21(4):242-5. PubMed ID: 17616354
[TBL] [Abstract][Full Text] [Related]
11. Lack of association of angiotensin II type 1 receptor gene polymorphism with diabetic nephropathy in insulin-dependent diabetes mellitus.
Chowdhury TA; Dyer PH; Kumar S; Gough SC; Gibson SP; Rowe BR; Smith PR; Dronsfield MJ; Marshall SM; Mackin P; Dean JD; Morris PJ; Davies S; Dunger DB; Boulton AJ; Barnett AH; Bain SC
Diabet Med; 1997 Oct; 14(10):837-40. PubMed ID: 9371475
[TBL] [Abstract][Full Text] [Related]
12. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.
Summers AM; Coupes BM; Brennan MF; Ralph SA; Short CD; Brenchley PE
Nephrol Dial Transplant; 2005 Nov; 20(11):2427-32. PubMed ID: 16046504
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in the B-type natriuretic peptide (BNP) gene are associated with NT-proBNP levels but not with diabetic nephropathy or mortality in type 1 diabetic patients.
Lajer M; Tarnow L; Jorsal A; Parving HH
Nephrol Dial Transplant; 2007 Nov; 22(11):3235-9. PubMed ID: 17567649
[TBL] [Abstract][Full Text] [Related]
14. Cytokine gene polymorphisms as potential risk and protective factors in renal cell carcinoma.
Baştürk B; Yavaşçaoğlu I; Vuruşkan H; Göral G; Oktay B; Oral HB
Cytokine; 2005 Apr; 30(1):41-5. PubMed ID: 15784411
[TBL] [Abstract][Full Text] [Related]
15. Further evidence for the association of MMP9 with nephropathy in type 2 diabetes and application of DNA pooling technology to candidate gene screening.
Nair S; Phillips AO; Norton N; Spurlock G; Williams HJ; Craig KJ; Williams JD; Williams NM; Bowen T
J Nephrol; 2008; 21(3):400-5. PubMed ID: 18587729
[TBL] [Abstract][Full Text] [Related]
16. Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection--association between TGF-beta1 polymorphisms and hepatocellular carcinoma.
Migita K; Miyazoe S; Maeda Y; Daikoku M; Abiru S; Ueki T; Yano K; Nagaoka S; Matsumoto T; Nakao K; Hamasaki K; Yatsuhashi H; Ishibashi H; Eguchi K
J Hepatol; 2005 Apr; 42(4):505-10. PubMed ID: 15763337
[TBL] [Abstract][Full Text] [Related]
17. [The relationship between the gene polymorphism of TGF-beta1 and early renal injury in patients with essential hypertension, and the effect of the gene polymorphism of TGF- beta1 on the individual treatment with valsartan].
Zhao C; Wang YY; Xiao ZX; Wang YP; Zhang QY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):428-31. PubMed ID: 17680535
[TBL] [Abstract][Full Text] [Related]
18. Association of transforming growth factor-beta1 gene polymorphism in the development of Epstein-Barr virus-related hematologic diseases.
Hatta K; Morimoto A; Ishii E; Kimura H; Ueda I; Hibi S; Todo S; Sugimoto T; Imashuku S
Haematologica; 2007 Nov; 92(11):1470-4. PubMed ID: 18024394
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta1 polymorphisms in Korean patients with systemic sclerosis.
Lee EB; Kim JY; Lee YJ; Abdallah A; Lympany P; Song YW
Tissue Antigens; 2004 May; 63(5):491-5. PubMed ID: 15104684
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of cytokine gene polymorphisms for the development of end-stage renal disease.
Babel N; Gabdrakhmanova L; Hammer MH; Schoenemann C; Skrypnikov V; Poliak N; Volk HD; Reinke P
J Nephrol; 2006; 19(6):802-7. PubMed ID: 17173255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
